Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05826639 · ClinicalTrials.gov registry record
A Study of Endobiliary Radiofrequency Ablation in Malignant Biliary Obstructions
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 176
- Enrollment target
NCT05826639: Completed study, sponsored by Mayo Clinic.
NCT05826639 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 176 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05826639 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 176 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the impact of temperature-sensitive radiofrequency ablation (RFA) immediately before biliary stent placement on duration of biliary stent patency and re-intervention free survival. This is a research study meant to collect information to help other patients with malignant biliary strictures in the future.
Primary Outcome
Duration of stent patency over the 6 month follow-up period
Interventions
- OTHER No intervention
- PROCEDURE Temperature-sensitive radiofrequency ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2023-04-13 |
| Est. Completion | 2024-11-18 |
What the finished NCT05826639 record still lists
NCT05826639 is an observational study that tracks outcomes without assigning an intervention. The registered 176 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which No intervention is the first listed.
NCT05826639 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05826639 about?
NCT05826639 is a clinical study titled "A Study of Endobiliary Radiofrequency Ablation in Malignant Biliary Obstructions". The purpose of this study is to assess the impact of temperature-sensitive radiofrequency ablation (RFA) immediately before biliary stent placement on duration of biliary stent patency and re-intervention free survival. This is a research study meant to collect information to help other patients wit...
What is the current status of trial NCT05826639?
This trial is currently completed. The enrollment target is 176 participants. The study started on 2023-04-13. Estimated completion is 2024-11-18.
What interventions are being tested in trial NCT05826639?
The interventions under investigation include: No intervention (OTHER), Temperature-sensitive radiofrequency ablation (PROCEDURE).
Who is sponsoring clinical trial NCT05826639?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03304821 · 176 participants · Phase 2
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
- NCT03447938 · 176 participants · NA
The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
- NCT03824145 · 176 participants · NA
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
- NCT04177914 · 176 participants · Phase 3
HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI